Cargando…
Trends in US approvals: new biopharmaceuticals and vaccines
The efficient development and approval of new therapeutics and vaccines is vital to the health and welfare of patients. Tufts Center for the Study of Drug Development has collected and analyzed data for new protein therapeutics and vaccines approved in the USA during the past decade. Our results sug...
Autor principal: | Reichert, Janice M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119034/ https://www.ncbi.nlm.nih.gov/pubmed/16759723 http://dx.doi.org/10.1016/j.tibtech.2006.05.003 |
Ejemplares similares
-
Approval of the first biosimilar antibodies in Europe: A major landmark for the biopharmaceutical industry
por: Beck, Alain, et al.
Publicado: (2013) -
Trends in the Development and Approval of Monoclonal Antibodies for Viral Infections
por: Reichert, Janice M.
Publicado: (2012) -
The Relative Contributions of NIH and Private Sector Funding to the Approval of New Biopharmaceuticals
por: Schulthess, Duane, et al.
Publicado: (2022) -
Correction: The Relative Contributions of NIH and Private Sector Funding to the Approval of New Biopharmaceuticals
por: Schulthess, Duane, et al.
Publicado: (2022) -
Plant-made vaccine antigens and biopharmaceuticals
por: Daniell, Henry, et al.
Publicado: (2009)